Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$680M |
| 2 |
Microsoft
MSFT
|
+$506M |
| 3 |
UnitedHealth
UNH
|
+$393M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$381M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$348M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.24B |
| 2 |
Tesla
TSLA
|
+$450M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$444M |
| 4 |
TSMC
TSM
|
+$432M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$371M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 93.94% |
| 2 | Technology | 1.79% |
| 3 | Consumer Discretionary | 0.82% |
| 4 | Financials | 0.79% |
| 5 | Healthcare | 0.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4301
Sprott Physical Silver Trust
PSLV
$13.8B
| $4.21M | ﹤0.01% |
344,358
+243,946
| +243% | +$2.76M |
|
4302
Carlisle Companies
CSL
$14.2B
| $4.21M | ﹤0.01% |
11,285
-28,796
| -72% | -$10.7M |
|
4303
BancFirst
BANF
$3.71B
| $4.21M | ﹤0.01% |
34,053
-112
| -0.3% | -$13.3K |
|
4304
PUT
Zevra Therapeutics
ZVRA
$687M
| $4.2M | ﹤0.01% |
477,100
+177,800
| +59% | +$1.44M |
|
4305
AnaptysBio
ANAB
$1.67B
| $4.2M | ﹤0.01% |
189,327
+144,990
| +327% | +$3.03M |
|
|
LKFT
4306
PUT
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.89B
| $4.2M | ﹤0.01% |
150,100
-2,500
| -2% | -$67K |
|
4307
CALL
TC Energy
TRP
$64.4B
| $4.2M | ﹤0.01% |
86,100
-79,900
| -48% | -$3.92M |
|
4308
PUT
Knight Transportation
KNX
$10.9B
| $4.2M | ﹤0.01% |
94,900
+71,300
| +302% | +$3.03M |
|
4309
Ramaco Resources Class A
METC
$843M
| $4.2M | ﹤0.01% |
319,270
+271,071
| +562% | +$2.59M |
|
4310
CALL
ARK Blockchain & Fintech Innovation ETF
ARKF
$816M
| $4.2M | ﹤0.01% |
83,500
+16,400
| +24% | +$646K |
|
|
PPBI
4311
DELISTED
Pacific Premier Bancorp
PPBI
| $4.19M | ﹤0.01% |
198,855
+23,942
| +14% | +$498K |
|
4312
CALL
Iridium Communications
IRDM
$4.94B
| $4.19M | ﹤0.01% |
138,900
+100
| +0.1% | +$2.6K |
|
4313
Direxion Daily Gold Miners Index Bull 2X ETF
NUGT
$1.4B
| $4.18M | ﹤0.01% |
56,280
-70,522
| -56% | -$4.91M |
|
4314
PUT
CG Oncology
CGON
$6.59B
| $4.18M | ﹤0.01% |
+160,800
| New | +$3.87M |
|
4315
CALL
Donaldson
DCI
$10.7B
| $4.17M | ﹤0.01% |
60,200
-4,700
| -7% | -$316K |
|
4316
CALL
CGI
GIB
$15.5B
| $4.17M | ﹤0.01% |
39,800
+10,600
| +36% | +$1.12M |
|
4317
PUT
Revolution Medicines
RVMD
$44.6B
| $4.17M | ﹤0.01% |
113,400
-18,200
| -14% | -$699K |
|
4318
Clear Secure
YOU
$4.47B
| $4.17M | ﹤0.01% |
150,085
-230,867
| -61% | -$5.88M |
|
4319
PUT
Schwab US Large-Cap Growth ETF
SCHG
$63.1B
| $4.17M | ﹤0.01% |
142,600
+31,200
| +28% | +$825K |
|
4320
PUT
Beyond Meat
BYND
$238M
| $4.16M | ﹤0.01% |
39,767
-41,476
| -51% | -$3.6M |
|
4321
First Trust Water ETF
FIW
$1.89B
| $4.16M | ﹤0.01% |
38,527
-6,685
| -15% | -$688K |
|
|
SRDX
4322
PUT
DELISTED
Surmodics
SRDX
| $4.16M | ﹤0.01% |
140,000
+131,800
| +1,607% | +$3.8M |
|
4323
Krystal Biotech
KRYS
$10.4B
| $4.16M | ﹤0.01% |
30,252
-3,577
| -11% | -$525K |
|
4324
Banner Corp
BANR
$2.4B
| $4.16M | ﹤0.01% |
64,805
-356
| -0.5% | -$22K |
|
4325
Dorman Products
DORM
$3.84B
| $4.15M | ﹤0.01% |
33,853
+3,446
| +11% | +$419K |
|
Similar funds
Jeff Yass's Q2 2025 Portfolio in Review
As of Q2 2025, Jeff Yass held 14,080 positions worth $720B, up 23% from $586B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass's Q2 2025 filing shows 1,720 new, 5,716 increased, 5,055 reduced and 1,538 closed positions. Its largest new stake was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.24B.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, down from 94% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q2 2025 buy was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M.
- Jeff Yass added most to Apple in Q2 2025, an estimated $680M increase.
- Jeff Yass's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.24B.
- Jeff Yass fully exited Vanguard Intermediate-Term Bond ETF in Q2 2025, selling an estimated $61.8M.
- Jeff Yass's ten largest holdings make up 26% of its $720B portfolio in Q2 2025.
- Jeff Yass opened 1,720 new positions and closed 1,538 in Q2 2025.
- Jeff Yass's portfolio value rose 23% quarter-over-quarter to $720B.
Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.